Showing 1 - 10 of 3,693
Persistent link: https://www.econbiz.de/10011498384
also characterized by extensive regulation of almost every activity, from product development through manufacturing and …
Persistent link: https://www.econbiz.de/10014025576
Persistent link: https://www.econbiz.de/10010425130
character of public regulation, and the sharp rise in the cost per new approved drug are analyzed. Determining which new drugs …
Persistent link: https://www.econbiz.de/10014025164
this paper, we take a close look at competition among the generic entrants during the first three years after patent … expiration and examine whether there is a first mover advantage. We specify a random effect nested logit model of competition … that allows for competition between the brand drug and generics, and among multiple generic drugs. The model accommodates …
Persistent link: https://www.econbiz.de/10012709667
Seit dem Jahr 2003 können Krankenkassen mit pharmazeutischen Unternehmen Rabatte über Arzneimittel vereinbaren. Insbesondere im Generikabereich hat sich der Abschluss entsprechender Rabattverträge seitdem zu einem wichtigen Instrument der Krankenkassen zur Kosteneinsparung entwickelt.Für die...
Persistent link: https://www.econbiz.de/10011674988
Persistent link: https://www.econbiz.de/10010484966
briefly reviews the framework for the approval of generic biologics established under the Biologics Price Competition and …
Persistent link: https://www.econbiz.de/10014171299
Persistent link: https://www.econbiz.de/10011398826
Persistent link: https://www.econbiz.de/10012134811